Newsweek.Fifty-four percent of U.S. eligible voters either disagreed or strongly disagreed that under-16s can consent to such drugs, with 22 percent thinking they can.Treatment of trans-identifying children has become a major political issue over the past few years, with 19 Republican-controlled states passing laws either to ban or severely restrict gender-affirming healthcare for minors.
Opponents see the bills as an attack on the entire LGBTQ+ community and an attempt to roll back laws on gay rights, such as same-sex marriage, that now have widespread support.
Campaigners are also boycotting Target after the retailer sold LGBTQ+ themed clothing aimed at children as part of its Pride range.The latest polling was conducted for Newsweek by Redfield & Wilton Strategies, which surveyed 1,500 eligible voters in the U.S.
on April 30.When asked whether "children under the age of 16 are able to give informed consent to be prescribed puberty-blocking drugs," 12 percent of respondents agreed, and another 10 percent strongly agreed.